Sly Saint
Senior Member (Voting Rights)
A Food and Drug Administration panel today unanimously ruled that a medicine used by millions for a stuffy nose does not work.
Phenylephrine is the most common active compound in over-the-counter drugs like Benadryl Allergy Plus Congestion, Sudafed PE, and Tylenol Cold and Flu Severe Day & Night.
But an FDA panel said after a two-day review that the oral decongestant ‘is not effective’ at standard or even high doses.
Their ruling is not binding but it strongly suggests that the agency could soon heed their advice and pull its approval, which would force companies to pull or reformulate their products.
The ingredient is protected under the FDA’s Generally Recognized as Safe and Effective (GRASE) designation, but a reversal of its approval could mean manufacturers including Bayer and Johnson and Johnson might need to reformulate.
Phenylephrine is everywhere, so much so that nearly every nasal decongestant on pharmacy shelves contains it.
Drugs that contain it generated almost $ 1.8 billion in sales last year, according to data presented Monday by FDA officials.
A unanimous vote by the 16-member Nonprescription Drug Advisory panel could issue a major blow to the industry.
Today's ruling only applies to oral formulations of phenylephrine, which account for about one-fifth of the $2.2 billion market for oral decongestants.
FDA rules TODAY that ingredient in Benadryl and Sudafed from pharmacy shelves don't work | Daily Mail Online